INTRODUCTION: Papillon-Lefèvre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar keratoderma and severe, early onset periodontitis, which results from deficiency of cathepsin C activity secondary to mutations in the cathepsin C gene. To date, 13 different cathepsin C mutations have been reported in PLS patients, all of which are homozygous for a given mutation, reflecting consanguinity. AIM: To evaluate the generality of cathepsin C mutations in PLS, we studied an ethnically diverse group of 20 unrelated families. METHODS: Mutations were identified by direct automated sequencing of genomic DNA amplified for exonic regions and associated splice site junctions of the cathepsin C gene. Long range PCR was performed to determine the genomic structure of the cathepsin C gene. RESULTS: The cathepsin C gene spans over 46 kb, with six introns ranging in size from 1.6 to 22.4 kb. Eleven novel mutations and four previously reported mutations were identified in affected subjects from 14 families. Missense mutations were most common (9/15), followed by nonsense mutations (3/15), insertions (2/15), and deletions (1/15). Among these 14 probands, two were compound heterozygotes. Affected subjects with transgressions of the dermal lesions onto the knees or elbows or both had mutations in both the pro- and mature regions of the enzyme, although most were in the mature region. CONCLUSION: Mutations in the mature region of cathepsin C were more likely to be associated with the transgressions of the dermatological lesions, although the results were not statistically significant. A comprehensive list of all cathepsin C mutations described to date, representing 25 mutations from 32 families with PLS and related conditions, is also presented.
INTRODUCTION: Papillon-Lefèvre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar keratoderma and severe, early onset periodontitis, which results from deficiency of cathepsin C activity secondary to mutations in the cathepsin C gene. To date, 13 different cathepsin C mutations have been reported in PLSpatients, all of which are homozygous for a given mutation, reflecting consanguinity. AIM: To evaluate the generality of cathepsin C mutations in PLS, we studied an ethnically diverse group of 20 unrelated families. METHODS: Mutations were identified by direct automated sequencing of genomic DNA amplified for exonic regions and associated splice site junctions of the cathepsin C gene. Long range PCR was performed to determine the genomic structure of the cathepsin C gene. RESULTS: The cathepsin C gene spans over 46 kb, with six introns ranging in size from 1.6 to 22.4 kb. Eleven novel mutations and four previously reported mutations were identified in affected subjects from 14 families. Missense mutations were most common (9/15), followed by nonsense mutations (3/15), insertions (2/15), and deletions (1/15). Among these 14 probands, two were compound heterozygotes. Affected subjects with transgressions of the dermal lesions onto the knees or elbows or both had mutations in both the pro- and mature regions of the enzyme, although most were in the mature region. CONCLUSION: Mutations in the mature region of cathepsin C were more likely to be associated with the transgressions of the dermatological lesions, although the results were not statistically significant. A comprehensive list of all cathepsin C mutations described to date, representing 25 mutations from 32 families with PLS and related conditions, is also presented.
Authors: C Toomes; J James; A J Wood; C L Wu; D McCormick; N Lench; C Hewitt; L Moynihan; E Roberts; C G Woods; A Markham; M Wong; R Widmer; K A Ghaffar; M Pemberton; I R Hussein; S A Temtamy; R Davies; A P Read; P Sloan; M J Dixon; N S Thakker Journal: Nat Genet Date: 1999-12 Impact factor: 38.330
Authors: T C Hart; P S Hart; M D Michalec; Y Zhang; M L Marazita; M Cooper; O M Yassin; M Nusier; S Walker Journal: J Med Genet Date: 2000-02 Impact factor: 6.318
Authors: T C Hart; P S Hart; M D Michalec; Y Zhang; E Firatli; T E Van Dyke; A Stabholz; A Zlotogorski; L Shapira; W A Soskolne; A Zlorogorski Journal: J Med Genet Date: 2000-02 Impact factor: 6.318
Authors: Y Zhang; T Lundgren; S Renvert; D N Tatakis; E Firatli; C Uygur; P S Hart; M C Gorry; J J Marks; T C Hart Journal: J Med Genet Date: 2001-02 Impact factor: 6.318
Authors: Martin Horn; Miroslav Baudys; Zdenek Voburka; Ivan Kluh; Jirí Vondrásek; Michael Mares Journal: Protein Sci Date: 2002-04 Impact factor: 6.725
Authors: Christian D Sadik; Barbara Noack; Beate Schacher; Josef Pfeilschifter; Heiko Mühl; Peter Eickholz Journal: Clin Oral Investig Date: 2011-03-05 Impact factor: 3.573